N@N

IDRA, ASTC, IPCI, AVNW, CEP, KOP Are Seasonally Ripe To Go Down In the Next Five Weeks

February 20, 2012 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of IDERA PHARMACEUTICALS INC (NASDAQ:IDRA), ASTROTECH CORP (NASDAQ:ASTC), INTELLIPHARMACEUTICS INTERNA (NASDAQ:IPCI), AVIAT NETWORKS INC (NASDAQ:AVNW), Constellation Energy Partners LLC (NYSE:CEP), KOPPERS HOLDINGS INC. (NYSE:KOP) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at: http://www.squeezetrigger.com/services/strat/mh.php

The following stocks are expected to go Down:

     Symbol     Company                             Expected Return     Odds                    By The Following Date
     IDRA       IDERA PHARMACEUTICALS INC           -9.54%              75.00% (9 of 12)        Wednesday, February 29th 2012
     ASTC       ASTROTECH CORP                      -7.60%              75.00% (9 of 12)        Monday, February 27th 2012
     IPCI       INTELLIPHARMACEUTICS INTERNA        -4.78%              75.00% (9 of 12)        Wednesday, February 22nd 2012
     AVNW       AVIAT NETWORKS INC                  -4.18%              75.00% (9 of 12)        Tuesday, February 21st 2012
     CEP        Constellation Energy Partners LLC     -5.73%              100.00% (5 of 5)        Thursday, February 23rd 2012
     KOP        KOPPERS HOLDINGS INC.               -3.64%              66.67% (4 of 6)         Wednesday, February 22nd 2012

IDERA PHARMACEUTICALS INC (NASDAQ:IDRA) - Idera Pharmaceuticals, Inc., a biotechnology company, discovers and develops DNA- and RNA-based drug candidates for the treatment of infectious diseases, autoimmune and inflammatory diseases, cancer, and asthma and allergies, and for use as vaccine adjuvants. The company designs and creates proprietary Toll-Like Receptors (TLR) to modulate immune responses, including TLR agonist, a compound that stimulates an immune response through the targeted TLR; and TLR antagonist, a compound that blocks activation of an immune response through the targeted TLR. Its drug candidates include IMO-2125, a TLR9 agonist, which is in Phase 1 clinical trial for hepatitis C virus infection; and TLR7, 8, and 9 agonists that are in research stage for viral diseases. The company also develops IMO-3100, a dual TLR7/TLR9 antagonist, which is in preclinical development stage for autoimmune and inflammatory diseases, such as lupus, rheumatoid arthritis, multiple sclerosis, psoriasis, and colitis. In addition, its drug candidates also comprise TLR7 and TLR8 agonists that are in research stage for solid tumor cancers. The company has a licensing and collaboration agreement with Merck KGaA to research, develop, and commercialize TLR9 agonists for the treatment of cancer, excluding cancer vaccines; a license and research collaboration agreement with Merck & Co., Inc. to research, develop, and commercialize therapeutic and prophylactic vaccine products containing its TLR7, 8, and 9 agonists in the fields of cancer, infectious diseases, and Alzheimers disease; and a research collaboration and option agreement, and a license, development, and commercialization agreement with Novartis International Pharmaceutical, Ltd. to discover, develop, and commercialize TLR9 agonists for the treatment of asthma and allergies. The company was founded in 1989 and is based in Cambridge, Massachusetts.

ASTROTECH CORP (NASDAQ:ASTC) - Astrotech Corporation provides various products and services for the space industry in the United States. The company provides space hardware design and manufacturing services, research and logistics expertise, engineering and support services, and payload processing and integration services that support manned and unmanned missions to space. It offers satellite launch processing support to government and commercial customers for their complex communication, earth observation, and deep space satellites. The companys processing activities include satellite ground transportation; pre-launch hardware integration and testing; satellite encapsulation, fueling, and launch pad delivery; and communication linked launch control. It also develops 1st Detect, a miniature mass spectrometer for use on the ISS; Astrogenetix, a microgravity processing platform used for developing drugs; and AirWard, a shipping container designed to meet the specific requirements of the U.S. Department of Transportation to protect pressurized oxygen bottles from flame and heat during flight. The company was formerly known as SPACEHAB, Inc. and changed its name to Astrotech Corporation in 2009. Astrotech Corporation was founded in 1984 and is headquartered in Austin, Texas.

INTELLIPHARMACEUTICS INTERNA (NASDAQ:IPCI) - Intellipharmaceutics International Inc. engages in the research, development, and manufacture of novel and generic controlled and targeted release oral solid dosage drugs. The companys patented Hypermatrix technology is a multidimensional controlled-release drug delivery platform that can be applied to the development of various existing and new pharmaceuticals. It has a pipeline of 15 products in various stages of development in therapeutic areas, including neurology, cardiovascular, and GIT. The companys lead generic product under development includes generic Focalin XR (dexmethylphenidate hydrochloride), an extended-release capsule for the treatment of attention deficit hyperactivity disorder. Intellipharmaceutics has a license and commercialization agreement with Par Pharmaceutical, Inc. for the development and commercialization of generic Focalin XR. In addition, the company has two generic products filed with the FDA, including a generic of Effexor XR (venlafaxine hydrochloride) and Protonix (delayed release pantoprazole sodium). Its lead non-generic product under development is Rexista oxycodone, an abuse- and alcohol-resistant controlled-release oral oxycodone formulation for the relief of pain. The company also has products under late stage development, which consist of venlafaxine hydrochloride, an extended-release capsule for the treatment of symptoms of depressive disorder, generalized anxiety disorder, social anxiety disorder, and panic disorder; and carvedilol phosphate, an extended-release capsule for the treatment of hypertension and heart conditions. The company was formerly known as IntelliPharmaCeutics Ltd. and changed its name to Intellipharmaceutics International Inc. in October 2009. IntelliPharmaCeutics International Inc. was founded in 1998 and is based in Toronto, Canada.

AVIAT NETWORKS INC (NASDAQ:AVNW) - Aviat Networks, Inc. engages in the design, manufacture, and sale of a range of wireless networking products, solutions, and services worldwide. The company offers a product portfolio that addresses the needs of service providers and network operators addressing a range of applications, frequencies, capacities, and network topologies. Its product categories include 4G/WiMAX (fixed and mobile) broadband access, licensed and license-exempt point-to-point microwave radios, and element and network management software. The company offers broadband wireless access base stations and customer premises equipment based upon the IEEE 802.16d-2004 and 16e-2005 standards for fixed and mobile WiMAX; licensed point-to-point microwave radios that include Eclipse, a platform for nodal wireless transmission systems; TRuepoint, a platform for ultra-high capacity trunking applications; and Constellation, a family of medium-to-high-capacity point-to-point digital radios that operate in the 6, 7/8, and 10/11 GHz frequencies, which are designed for network applications and support both PDH and SONET. It also offers license-exempt wireless interconnection for wireless access, cellular backhaul, Internet service, local and wide area networking, and emergency response communications systems. In addition, the company provides NetBoss, a family of network management and service assurance solutions for managing multi-vendor, multi-technology communications networks; and ProVision, a centralized network monitoring and control system to manage wireless transmission networks. The company also offers professional services, including installation and commissioning and training. It serves mobile and fixed telephone service providers, private network operators, government agencies, transportation and utility companies, public safety agencies, and broadcast system operators. Aviat Networks, Inc. is headquartered in Santa Clara, California.

Constellation Energy Partners LLC (NYSE:CEP) - Constellation Energy Partners LLC engages in the acquisition, development, and production of oil and natural gas properties, as well as related midstream assets in the United States. It has interests in the Black Warrior Basin in Alabama, the Cherokee Basin in Kansas and Oklahoma, and the Woodford Shale in the Arkoma Basin in Oklahoma. As of December 31, 2009, the company had approximately 131.2 Bcfe of estimated proved reserves; and owned approximately 2,760 net producing wells. The company was formerly known as Constellation Energy Resources LLC and changed its name to Constellation Energy Partners LLC in July 2006. Constellation Energy Partners was founded in 2005 and is headquartered in Houston, Texas.

KOPPERS HOLDINGS INC. (NYSE:KOP) - Koppers Holdings Inc., through its subsidiaries, provides carbon compounds and commercial wood treatment products to aluminum, railroad, specialty chemical, utility, rubber, concrete, and steel industries. The company operates in two segments, Carbon Materials and Chemicals, and Railroad and Utility Products. The Carbon Materials and Chemicals segment engages in the distillation of coal tar in North America, Europe, Australia, and China. It supplies carbon pitch used in the production of aluminum and for the production of steel in electric arc furnaces; naphthalene used for the production of phthalic anhydride and as a surfactant in the production of concrete; phthalic anhydride used in the production of plasticizers, polyester resins, and alkyd paints; creosote used in the treatment of wood; carbon black feedstock used in the production of carbon black; and carbon black used primarily in the production of rubber tires. This segment also sells refined tars, benzole, and specialty chemicals. The Railroad and Utility Products segment sells treated and untreated wood products and services primarily to the railroad and public utility markets in the United States and Australia. This segment involves in procuring and treating items, such as crossties, switch ties, and various types of lumber used for railroad bridges and crossings. It also offers utility products, including transmission and distribution poles and pilings to electric and telephone utility industries. The company was formerly known as KI Holdings, Inc. Koppers Holdings Inc. was founded in 1988 and is based in Pittsburgh, Pennsylvania.

SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com

www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.

INVESTMENTS & TRADING

SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

About SQUEEZETRIGGER.COM

WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.

SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.

Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.

By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.

Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641